Followers | 234 |
Posts | 26887 |
Boards Moderated | 0 |
Alias Born | 01/12/2013 |
Tuesday, September 02, 2014 9:38:55 PM
https://www.lipid.org/nla/national-lipid-association-launches-nationwide-triglyceride-campaign-during-national-cholesterol
Fairly significant development....
National Lipid Association Launches Nationwide Triglyceride Campaign during National Cholesterol Education Month
You are here
Recent survey shows need for triglyceride testing and improved reporting by health care providers
JACKSONVILLE, Fla. (September 2014) — In response to recent survey findings, the National Lipid Association (NLA) announces a nationwide educational campaign to raise awareness within target consumer audiences. Their goal is to encourage patient education and drive discussions around lipid management and the resulting consequences for high cholesterol and triglycerides.
To activate this effort, throughout the month of September, also known as National Cholesterol Education Month, health care providers are encouraged to inform at-risk patients about the impact of proper treatment and prevention of complications for their entire lipid profile — not limited to cholesterol, but on elevated triglyceride levels also.
“We want to raise awareness around elevated triglycerides with patients and health care providers alike, as they may unsuspectingly affect patients’ health, even if they look and feel healthy,” said NLA President Terry A. Jacobson, MD. “Fortunately, health care providers are committed to offering their patients their best care, and we’re committed to ensuring they have the tools to do so.”
In a recent survey of health care providers, the NLA discovered the need for standard protocols to remind practitioners to measure and help patients manage their total lipid profile, including triglycerides. The survey also found that health care providers would welcome patient education tools to help consumers understand the importance of triglycerides and preferred ways to keep their number low.
To jumpstart these educational and preventive efforts, the NLA urges health care providers to compare their patients’ triglyceride levels to the following categories:
Normal: less than 150 mg/dL
Borderline high: 150-199 mg/dL
High: 200-499 mg/dL
Very high: 500 mg/dL or more
“If your patients’ triglyceride level is 150 mg/dL or above, you need to engage in a more comprehensive discussion about triglycerides with them,” said Dr. Jacobson. “Patients need to be aware of the potential causes of elevated triglyceride levels, which include diets high in fat and sugar, too much alcohol, not enough exercise and health conditions like diabetes and obesity.” According to Dr. Jacobson, “we are now learning that high triglycerides may be a very important risk factor for heart disease and stroke.”
The NLA’s main focus is providing resources for clinical practice and education, and generating awareness around lipid management for our membership. To support this initiative, the NLA will be releasing clinical recommendations mid-September on a patient-centered approach to managing dyslipidemia.
For more information and patient tools, health care providers may visit lipid.org/whats-your-number. Patients may visit learnyourlipids.com.
About NLA
Founded in 2002, the 3,000 members of the National Lipid Association share a common goal: to enhance the practice of lipid management in clinical medicine and to reduce the morbidity and mortality associated with atherosclerotic disease. The specialty of lipidology is building momentum and continues to evolve with the field of medicine as a whole. In the past three years alone, changes in the field of study have redefined the identity and the area of science. In response to demographic trends that place an increasing number of Americans at risk for coronary heart disease (CHD) and epidemic levels of obesity concurrent with a surge in new cases of diabetes mellitus, the field continues to grow rapidly and to gain momentum in the medical community. More information can be found at lipid.org.
Recent AMRN News
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:00:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:31:21 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM